epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Zycubo

copper histidinate

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Adult dosing is currently unavailable or not applicable for this drug.

Peds Dosing .

Dosage forms:  INJ

Menkes disease

[<1 yo]
Dose: 1.45 mg SC bid
[1-16 yo]
Dose: 1.45 mg SC qd

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[not defined]

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@41f455a5
  • hypersensitivity to drug or ingredient

Drug Interactions .

Overview

copper histidinate

Interaction Characteristics:
  • heavy metal
  • myelosuppressive effects
  • nephrotoxicity

Contraindicated

  • cidofovir
  • Zycubo (copper histidinate)
    +
    cidofovir
    1 interaction

    Contraindicated

    copper histidinate + cidofovir

    contraindicated; D/C copper histidinate at least 7 days prior to cidofovir tx: combo may incr. cidofovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

Avoid/Use Alternative

  • aldesleukin
  • Zycubo (copper histidinate)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    copper histidinate + aldesleukin

    use alternative or monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • amikacin
  • Zycubo (copper histidinate)
    +
    amikacin
    1 interaction

    Avoid/Use Alternative

    copper histidinate + amikacin

    use alternative or monitor amikacin levels, renal fxn, electrolytes, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amikacin inhaled
  • Zycubo (copper histidinate)
    +
    amikacin inhaled
    1 interaction

    Avoid/Use Alternative

    copper histidinate + amikacin inhaled

    use alternative or monitor renal fxn, electrolytes, ototoxicity: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • bumetanide
  • Zycubo (copper histidinate)
    +
    bumetanide
    1 interaction

    Avoid/Use Alternative

    copper histidinate + bumetanide

    use alternative or monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • chloramphenicol
  • Zycubo (copper histidinate)
    +
    chloramphenicol
    1 interaction

    Avoid/Use Alternative

    copper histidinate + chloramphenicol

    use alternative or monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • cladribine oral
  • Zycubo (copper histidinate)
    +
    cladribine oral
    1 interaction

    Avoid/Use Alternative

    copper histidinate + cladribine oral

    use alternative or monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • clofarabine
  • Zycubo (copper histidinate)
    +
    clofarabine
    1 interaction

    Avoid/Use Alternative

    copper histidinate + clofarabine

    avoid copper histidinate during 5 day clofarabine tx; monitor CBC, renal fxn, electrolytes, BP: combo may incr. clofarabine levels, risk of serious infection, myelosuppression, nephrotoxicity, hypotension, other adverse effects (additive effects)

  • deferiprone
  • Zycubo (copper histidinate)
    +
    deferiprone
    1 interaction

    Avoid/Use Alternative

    copper histidinate + deferiprone

    use alternative or monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • fexinidazole
  • Zycubo (copper histidinate)
    +
    fexinidazole
    1 interaction

    Avoid/Use Alternative

    copper histidinate + fexinidazole

    use alternative or monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • foscarnet
  • Zycubo (copper histidinate)
    +
    foscarnet
    1 interaction

    Avoid/Use Alternative

    copper histidinate + foscarnet

    use alternative or monitor CBC, renal fxn, electrolytes: combo may incr. foscarnet levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • ganciclovir
  • Zycubo (copper histidinate)
    +
    ganciclovir
    1 interaction

    Avoid/Use Alternative

    copper histidinate + ganciclovir

    use alternative or monitor CBC, renal fxn, electrolytes: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • gentamicin
  • Zycubo (copper histidinate)
    +
    gentamicin
    1 interaction

    Avoid/Use Alternative

    copper histidinate + gentamicin

    use alternative or monitor gentamicin levels, renal fxn, electrolytes, ototoxicity: combo may incr. gentamicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • mannitol
  • Zycubo (copper histidinate)
    +
    mannitol
    1 interaction

    Avoid/Use Alternative

    copper histidinate + mannitol

    use alternative or monitor renal fxn, electrolytes: combo may incr. mannitol levels, risk of nephrotoxicity, neurotoxicity (including life-threatening), other adverse effects (additive effects)

  • methotrexate
  • Zycubo (copper histidinate)
    +
    methotrexate
    1 interaction

    Avoid/Use Alternative

    copper histidinate + methotrexate

    use alternative or monitor CBC, renal fxn, electrolytes: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • oxaliplatin
  • Zycubo (copper histidinate)
    +
    oxaliplatin
    1 interaction

    Avoid/Use Alternative

    copper histidinate + oxaliplatin

    use alternative or monitor ECG, CBC, renal fxn, electrolytes, ototoxicity: combo may incr. oxaliplatin levels, risk of QT prolongation, cardiac arrhythmias, serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • penicillamine
  • Zycubo (copper histidinate)
    +
    penicillamine
    1 interaction

    Avoid/Use Alternative

    copper histidinate + penicillamine

    avoid combo: combo may incr. penicillamine levels, risk of myelosuppression, nephrotoxicity, other adverse effects; may decr. copper histidinate levels, efficacy (additive effects; chelation)

  • pentamidine
  • Zycubo (copper histidinate)
    +
    pentamidine
    1 interaction

    Avoid/Use Alternative

    copper histidinate + pentamidine

    use alternative or monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • polymyxin B
  • Zycubo (copper histidinate)
    +
    polymyxin B
    1 interaction

    Avoid/Use Alternative

    copper histidinate + polymyxin B

    avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • primaquine
  • Zycubo (copper histidinate)
    +
    primaquine
    1 interaction

    Avoid/Use Alternative

    copper histidinate + primaquine

    use alternative or monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • radium Ra 223 dichloride
  • Zycubo (copper histidinate)
    +
    radium Ra 223 dichloride
    1 interaction

    Avoid/Use Alternative

    copper histidinate + radium Ra 223 dichloride

    use alternative or monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ropeginterferon alfa-2b
  • Zycubo (copper histidinate)
    +
    ropeginterferon alfa-2b
    1 interaction

    Avoid/Use Alternative

    copper histidinate + ropeginterferon alfa-2b

    use alternative or monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • streptomycin
  • Zycubo (copper histidinate)
    +
    streptomycin
    1 interaction

    Avoid/Use Alternative

    copper histidinate + streptomycin

    use alternative or monitor renal fxn, electrolytes, ototoxicity: combo may incr. streptomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • streptozocin
  • Zycubo (copper histidinate)
    +
    streptozocin
    1 interaction

    Avoid/Use Alternative

    copper histidinate + streptozocin

    use alternative or monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • tenofovir disoproxil
  • Zycubo (copper histidinate)
    +
    tenofovir disoproxil
    1 interaction

    Avoid/Use Alternative

    copper histidinate + tenofovir disoproxil

    use alternative or monitor renal fxn, electrolytes: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tobramycin inhaled
  • Zycubo (copper histidinate)
    +
    tobramycin inhaled
    1 interaction

    Avoid/Use Alternative

    copper histidinate + tobramycin inhaled

    use alternative or monitor renal fxn, electrolytes, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • valganciclovir
  • Zycubo (copper histidinate)
    +
    valganciclovir
    1 interaction

    Avoid/Use Alternative

    copper histidinate + valganciclovir

    use alternative or monitor CBC, renal fxn, electrolytes: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

Monitor/Modify Tx

  • abemaciclib
  • Zycubo (copper histidinate)
    +
    abemaciclib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + abemaciclib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • acalabrutinib
  • Zycubo (copper histidinate)
    +
    acalabrutinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + acalabrutinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • acyclovir
  • Zycubo (copper histidinate)
    +
    acyclovir
    1 interaction

    Monitor/Modify Tx

    copper histidinate + acyclovir

    monitor renal fxn, electrolytes: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • adefovir dipivoxil
  • Zycubo (copper histidinate)
    +
    adefovir dipivoxil
    1 interaction

    Monitor/Modify Tx

    copper histidinate + adefovir dipivoxil

    monitor renal fxn, electrolytes: combo may incr. adefovir levels, risk of nephrotoxicity, other adverse effects (renal excretion decreased by nephrotoxic agents, additive effects)

  • ado-trastuzumab emtansine
  • Zycubo (copper histidinate)
    +
    ado-trastuzumab emtansine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ado-trastuzumab emtansine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • afamitresgene autoleucel
  • Zycubo (copper histidinate)
    +
    afamitresgene autoleucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + afamitresgene autoleucel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • albendazole
  • Zycubo (copper histidinate)
    +
    albendazole
    1 interaction

    Monitor/Modify Tx

    copper histidinate + albendazole

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • alectinib
  • Zycubo (copper histidinate)
    +
    alectinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + alectinib

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • alemtuzumab
  • Zycubo (copper histidinate)
    +
    alemtuzumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + alemtuzumab

    monitor CBC; myelosuppression risk may be lower w/ alemtuzumab doses used for MS: combo may incr. risk of myelosuppression (additive effects)

  • aliskiren
  • Zycubo (copper histidinate)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    copper histidinate + aliskiren

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • allopurinol
  • Zycubo (copper histidinate)
    +
    allopurinol
    1 interaction

    Monitor/Modify Tx

    copper histidinate + allopurinol

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • amiloride
  • Zycubo (copper histidinate)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    copper histidinate + amiloride

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • amphotericin
  • Zycubo (copper histidinate)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + amphotericin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • anthrax immune globulin
  • Zycubo (copper histidinate)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + anthrax immune globulin

    monitor renal fxn, electrolytes; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • anti-thymocyte globulin
  • Zycubo (copper histidinate)
    +
    anti-thymocyte globulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + anti-thymocyte globulin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • arsenic trioxide
  • Zycubo (copper histidinate)
    +
    arsenic trioxide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + arsenic trioxide

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • asciminib
  • Zycubo (copper histidinate)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + asciminib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • aspirin
  • Zycubo (copper histidinate)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + aspirin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • atidarsagene autotemcel
  • Zycubo (copper histidinate)
    +
    atidarsagene autotemcel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + atidarsagene autotemcel

    monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression (additive effects)

  • auranofin
  • Zycubo (copper histidinate)
    +
    auranofin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + auranofin

    monitor CBC, renal fxn, electrolytes: combo may incr. auranofin levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • axicabtagene ciloleucel
  • Zycubo (copper histidinate)
    +
    axicabtagene ciloleucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + axicabtagene ciloleucel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • axitinib
  • Zycubo (copper histidinate)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + axitinib

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • azacitidine
  • Zycubo (copper histidinate)
    +
    azacitidine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + azacitidine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • azathioprine
  • Zycubo (copper histidinate)
    +
    azathioprine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + azathioprine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • azilsartan medoxomil
  • Zycubo (copper histidinate)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    copper histidinate + azilsartan medoxomil

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • balsalazide
  • Zycubo (copper histidinate)
    +
    balsalazide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + balsalazide

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • baricitinib
  • Zycubo (copper histidinate)
    +
    baricitinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + baricitinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • belantamab mafodotin
  • Zycubo (copper histidinate)
    +
    belantamab mafodotin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + belantamab mafodotin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • belinostat
  • Zycubo (copper histidinate)
    +
    belinostat
    1 interaction

    Monitor/Modify Tx

    copper histidinate + belinostat

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • benazepril
  • Zycubo (copper histidinate)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + benazepril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • bendamustine
  • Zycubo (copper histidinate)
    +
    bendamustine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + bendamustine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • benznidazole
  • Zycubo (copper histidinate)
    +
    benznidazole
    1 interaction

    Monitor/Modify Tx

    copper histidinate + benznidazole

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • betibeglogene autotemcel
  • Zycubo (copper histidinate)
    +
    betibeglogene autotemcel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + betibeglogene autotemcel

    monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression (additive effects)

  • bevacizumab
  • Zycubo (copper histidinate)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + bevacizumab

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • bexarotene
  • Zycubo (copper histidinate)
    +
    bexarotene
    1 interaction

    Monitor/Modify Tx

    copper histidinate + bexarotene

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • bleomycin
  • Zycubo (copper histidinate)
    +
    bleomycin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + bleomycin

    monitor renal fxn, electrolytes; decr. bleomycin dose based on CrCl: combo may incr. bleomycin levels, risk of pulmonary toxicities (including life-threatening), other adverse effects (renal excretion decreased)

  • blinatumomab
  • Zycubo (copper histidinate)
    +
    blinatumomab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + blinatumomab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • bortezomib
  • Zycubo (copper histidinate)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + bortezomib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • bosutinib
  • Zycubo (copper histidinate)
    +
    bosutinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + bosutinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • botulism immune globulin
  • Zycubo (copper histidinate)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + botulism immune globulin

    monitor renal fxn, electrolytes; use lowest botulism immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • brentuximab vedotin
  • Zycubo (copper histidinate)
    +
    brentuximab vedotin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + brentuximab vedotin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • brexucabtagene autoleucel
  • Zycubo (copper histidinate)
    +
    brexucabtagene autoleucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + brexucabtagene autoleucel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • busulfan
  • Zycubo (copper histidinate)
    +
    busulfan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + busulfan

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • cabazitaxel
  • Zycubo (copper histidinate)
    +
    cabazitaxel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + cabazitaxel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • cabozantinib
  • Zycubo (copper histidinate)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + cabozantinib

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • candesartan cilexetil
  • Zycubo (copper histidinate)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    copper histidinate + candesartan cilexetil

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • capecitabine
  • Zycubo (copper histidinate)
    +
    capecitabine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + capecitabine

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • captopril
  • Zycubo (copper histidinate)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + captopril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • carboplatin
  • Zycubo (copper histidinate)
    +
    carboplatin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + carboplatin

    monitor CBC, renal fxn, electrolytes, ototoxicity: combo may incr. carboplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • carfilzomib
  • Zycubo (copper histidinate)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + carfilzomib

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • carmustine
  • Zycubo (copper histidinate)
    +
    carmustine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + carmustine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • celecoxib
  • Zycubo (copper histidinate)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + celecoxib

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • chlorambucil
  • Zycubo (copper histidinate)
    +
    chlorambucil
    1 interaction

    Monitor/Modify Tx

    copper histidinate + chlorambucil

    monitor CBC, consider chlorambucil dose adjustment: combo may incr. risk of myelosuppression (additive effects)

  • chlorothiazide
  • Zycubo (copper histidinate)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + chlorothiazide

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • chlorthalidone
  • Zycubo (copper histidinate)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    copper histidinate + chlorthalidone

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • ciltacabtagene autoleucel
  • Zycubo (copper histidinate)
    +
    ciltacabtagene autoleucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ciltacabtagene autoleucel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • cisplatin
  • Zycubo (copper histidinate)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + cisplatin

    monitor CBC, renal fxn, electrolytes, ototoxicity: combo may incr. cisplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • cladribine injection
  • Zycubo (copper histidinate)
    +
    cladribine injection
    1 interaction

    Monitor/Modify Tx

    copper histidinate + cladribine injection

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • clindamycin
  • Zycubo (copper histidinate)
    +
    clindamycin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + clindamycin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • clozapine
  • Zycubo (copper histidinate)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + clozapine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • colchicine
  • Zycubo (copper histidinate)
    +
    colchicine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + colchicine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • colistimethate
  • Zycubo (copper histidinate)
    +
    colistimethate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + colistimethate

    monitor renal fxn, electrolytes: combo may incr. colistimethate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • copanlisib
  • Zycubo (copper histidinate)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + copanlisib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • creatine
  • Zycubo (copper histidinate)
    +
    creatine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + creatine

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • crizotinib
  • Zycubo (copper histidinate)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + crizotinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • cyclophosphamide
  • Zycubo (copper histidinate)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + cyclophosphamide

    monitor CBC, electrolytes, renal, cardiac fxn: combo may incr. cyclophosphamide levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • cyclosporine
  • Zycubo (copper histidinate)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + cyclosporine

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • cytarabine
  • Zycubo (copper histidinate)
    +
    cytarabine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + cytarabine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • cytomegalovirus immune globulin
  • Zycubo (copper histidinate)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + cytomegalovirus immune globulin

    monitor renal fxn, electrolytes; use lowest cytomegalovirus immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • dacarbazine
  • Zycubo (copper histidinate)
    +
    dacarbazine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + dacarbazine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • dactinomycin
  • Zycubo (copper histidinate)
    +
    dactinomycin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + dactinomycin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • dapsone
  • Zycubo (copper histidinate)
    +
    dapsone
    1 interaction

    Monitor/Modify Tx

    copper histidinate + dapsone

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • daratumumab
  • Zycubo (copper histidinate)
    +
    daratumumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + daratumumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • dasatinib
  • Zycubo (copper histidinate)
    +
    dasatinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + dasatinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • daunorubicin
  • Zycubo (copper histidinate)
    +
    daunorubicin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + daunorubicin

    monitor CBC, bleeding signs/symptoms: combo may incr. risk of myelosuppression, bleeding, including life-threatening (additive effects)

  • decitabine
  • Zycubo (copper histidinate)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + decitabine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • deferasirox
  • Zycubo (copper histidinate)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    copper histidinate + deferasirox

    monitor CBC, renal fxn, electrolytes, ototoxicity: combo may incr. deferasirox levels, risk of myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • deferoxamine
  • Zycubo (copper histidinate)
    +
    deferoxamine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + deferoxamine

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • deuruxolitinib
  • Zycubo (copper histidinate)
    +
    deuruxolitinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + deuruxolitinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • dexrazoxane
  • Zycubo (copper histidinate)
    +
    dexrazoxane
    1 interaction

    Monitor/Modify Tx

    copper histidinate + dexrazoxane

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • diclofenac
  • Zycubo (copper histidinate)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    copper histidinate + diclofenac

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • diclofenac topical
  • Zycubo (copper histidinate)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    copper histidinate + diclofenac topical

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • diflunisal
  • Zycubo (copper histidinate)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    copper histidinate + diflunisal

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • dinutuximab
  • Zycubo (copper histidinate)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + dinutuximab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • docetaxel
  • Zycubo (copper histidinate)
    +
    docetaxel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + docetaxel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • dostarlimab
  • Zycubo (copper histidinate)
    +
    dostarlimab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + dostarlimab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • doxorubicin
  • Zycubo (copper histidinate)
    +
    doxorubicin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + doxorubicin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • duvelisib
  • Zycubo (copper histidinate)
    +
    duvelisib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + duvelisib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • eflornithine
  • Zycubo (copper histidinate)
    +
    eflornithine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + eflornithine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • elivaldogene autotemcel
  • Zycubo (copper histidinate)
    +
    elivaldogene autotemcel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + elivaldogene autotemcel

    monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression (additive effects)

  • elranatamab
  • Zycubo (copper histidinate)
    +
    elranatamab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + elranatamab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • enalapril
  • Zycubo (copper histidinate)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + enalapril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • enalaprilat
  • Zycubo (copper histidinate)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    copper histidinate + enalaprilat

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • enfortumab vedotin
  • Zycubo (copper histidinate)
    +
    enfortumab vedotin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + enfortumab vedotin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • entrectinib
  • Zycubo (copper histidinate)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + entrectinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • epcoritamab
  • Zycubo (copper histidinate)
    +
    epcoritamab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + epcoritamab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • epirubicin
  • Zycubo (copper histidinate)
    +
    epirubicin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + epirubicin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • eribulin
  • Zycubo (copper histidinate)
    +
    eribulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + eribulin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ethacrynic acid
  • Zycubo (copper histidinate)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ethacrynic acid

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • etodolac
  • Zycubo (copper histidinate)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    copper histidinate + etodolac

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • etoposide
  • Zycubo (copper histidinate)
    +
    etoposide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + etoposide

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • etuvetidigene autotemcel
  • Zycubo (copper histidinate)
    +
    etuvetidigene autotemcel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + etuvetidigene autotemcel

    monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression, bleeding (additive effects)

  • everolimus
  • Zycubo (copper histidinate)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    copper histidinate + everolimus

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • exagamglogene autotemcel
  • Zycubo (copper histidinate)
    +
    exagamglogene autotemcel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + exagamglogene autotemcel

    monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression, bleeding (additive effects)

  • fam-trastuzumab deruxtecan
  • Zycubo (copper histidinate)
    +
    fam-trastuzumab deruxtecan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fam-trastuzumab deruxtecan

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • fedratinib
  • Zycubo (copper histidinate)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fedratinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • fenoprofen
  • Zycubo (copper histidinate)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fenoprofen

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • floxuridine
  • Zycubo (copper histidinate)
    +
    floxuridine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + floxuridine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • flucytosine
  • Zycubo (copper histidinate)
    +
    flucytosine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + flucytosine

    monitor CBC, renal fxn, electrolytes, flucytosine levels: combo may incr. flucytosine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • fludarabine
  • Zycubo (copper histidinate)
    +
    fludarabine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fludarabine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • fluorouracil
  • Zycubo (copper histidinate)
    +
    fluorouracil
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fluorouracil

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • fluphenazine
  • Zycubo (copper histidinate)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fluphenazine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • flurbiprofen
  • Zycubo (copper histidinate)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    copper histidinate + flurbiprofen

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • fosfomycin injection
  • Zycubo (copper histidinate)
    +
    fosfomycin injection
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fosfomycin injection

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • fosinopril
  • Zycubo (copper histidinate)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fosinopril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • fostamatinib
  • Zycubo (copper histidinate)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + fostamatinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • furosemide
  • Zycubo (copper histidinate)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + furosemide

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • gemcitabine
  • Zycubo (copper histidinate)
    +
    gemcitabine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + gemcitabine

    monitor CBC; risk may be lower w/ intravesical gemcitabine administration: combo may incr. risk of myelosuppression (additive effects)

  • gemtuzumab ozogamicin
  • Zycubo (copper histidinate)
    +
    gemtuzumab ozogamicin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + gemtuzumab ozogamicin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • givinostat
  • Zycubo (copper histidinate)
    +
    givinostat
    1 interaction

    Monitor/Modify Tx

    copper histidinate + givinostat

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • glasdegib
  • Zycubo (copper histidinate)
    +
    glasdegib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + glasdegib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • glofitamab
  • Zycubo (copper histidinate)
    +
    glofitamab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + glofitamab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • hydrochlorothiazide
  • Zycubo (copper histidinate)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + hydrochlorothiazide

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • hydroxocobalamin IV
  • Zycubo (copper histidinate)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    copper histidinate + hydroxocobalamin IV

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • hydroxychloroquine
  • Zycubo (copper histidinate)
    +
    hydroxychloroquine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + hydroxychloroquine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • hydroxyurea
  • Zycubo (copper histidinate)
    +
    hydroxyurea
    1 interaction

    Monitor/Modify Tx

    copper histidinate + hydroxyurea

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ibritumomab tiuxetan
  • Zycubo (copper histidinate)
    +
    ibritumomab tiuxetan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ibritumomab tiuxetan

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ibrutinib
  • Zycubo (copper histidinate)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ibrutinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ibuprofen
  • Zycubo (copper histidinate)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ibuprofen

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • ibuprofen lysine
  • Zycubo (copper histidinate)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ibuprofen lysine

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • idarubicin
  • Zycubo (copper histidinate)
    +
    idarubicin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + idarubicin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • idecabtagene vicleucel
  • Zycubo (copper histidinate)
    +
    idecabtagene vicleucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + idecabtagene vicleucel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • idelalisib
  • Zycubo (copper histidinate)
    +
    idelalisib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + idelalisib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ifosfamide
  • Zycubo (copper histidinate)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ifosfamide

    monitor CBC, electrolytes, renal, cardiac fxn: combo may incr. ifosfamide levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • imatinib
  • Zycubo (copper histidinate)
    +
    imatinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + imatinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • imetelstat
  • Zycubo (copper histidinate)
    +
    imetelstat
    1 interaction

    Monitor/Modify Tx

    copper histidinate + imetelstat

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • immune globulin
  • Zycubo (copper histidinate)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + immune globulin

    monitor renal fxn, electrolytes; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • indapamide
  • Zycubo (copper histidinate)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + indapamide

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • indomethacin
  • Zycubo (copper histidinate)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + indomethacin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • inotuzumab ozogamicin
  • Zycubo (copper histidinate)
    +
    inotuzumab ozogamicin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + inotuzumab ozogamicin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • interferon beta 1a
  • Zycubo (copper histidinate)
    +
    interferon beta 1a
    1 interaction

    Monitor/Modify Tx

    copper histidinate + interferon beta 1a

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • interferon beta 1b
  • Zycubo (copper histidinate)
    +
    interferon beta 1b
    1 interaction

    Monitor/Modify Tx

    copper histidinate + interferon beta 1b

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • interferon gamma 1b
  • Zycubo (copper histidinate)
    +
    interferon gamma 1b
    1 interaction

    Monitor/Modify Tx

    copper histidinate + interferon gamma 1b

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • iodixanol
  • Zycubo (copper histidinate)
    +
    iodixanol
    1 interaction

    Monitor/Modify Tx

    copper histidinate + iodixanol

    monitor renal function, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • iohexol
  • Zycubo (copper histidinate)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    copper histidinate + iohexol

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • iomeprol
  • Zycubo (copper histidinate)
    +
    iomeprol
    1 interaction

    Monitor/Modify Tx

    copper histidinate + iomeprol

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • iopamidol
  • Zycubo (copper histidinate)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    copper histidinate + iopamidol

    if IV iopamidol use, monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • iopromide
  • Zycubo (copper histidinate)
    +
    iopromide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + iopromide

    monitor renal function, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • iothalamate meglumine
  • Zycubo (copper histidinate)
    +
    iothalamate meglumine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + iothalamate meglumine

    if IV iothalamate meglumine use, monitor renal function, electrolytes; retrograde cystography and cystourethrography use OK: combo may incr. risk of nephrotoxicity (additive effects)

  • ioversol
  • Zycubo (copper histidinate)
    +
    ioversol
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ioversol

    monitor renal function: combo may incr. risk of nephrotoxicity (additive effects)

  • irbesartan
  • Zycubo (copper histidinate)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + irbesartan

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • irinotecan
  • Zycubo (copper histidinate)
    +
    irinotecan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + irinotecan

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • isatuximab
  • Zycubo (copper histidinate)
    +
    isatuximab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + isatuximab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ivosidenib
  • Zycubo (copper histidinate)
    +
    ivosidenib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ivosidenib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ixabepilone
  • Zycubo (copper histidinate)
    +
    ixabepilone
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ixabepilone

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ketoprofen
  • Zycubo (copper histidinate)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ketoprofen

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • ketorolac
  • Zycubo (copper histidinate)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ketorolac

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • leflunomide
  • Zycubo (copper histidinate)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + leflunomide

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • lenalidomide
  • Zycubo (copper histidinate)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lenalidomide

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • lenvatinib
  • Zycubo (copper histidinate)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lenvatinib

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • lifileucel
  • Zycubo (copper histidinate)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lifileucel

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • linezolid
  • Zycubo (copper histidinate)
    +
    linezolid
    1 interaction

    Monitor/Modify Tx

    copper histidinate + linezolid

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • linvoseltamab
  • Zycubo (copper histidinate)
    +
    linvoseltamab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + linvoseltamab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • lisinopril
  • Zycubo (copper histidinate)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lisinopril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • lisocabtagene maraleucel
  • Zycubo (copper histidinate)
    +
    lisocabtagene maraleucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lisocabtagene maraleucel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • lithium
  • Zycubo (copper histidinate)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lithium

    monitor lithium levels, renal fxn, electrolytes: combo may incr. lithium levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • lomustine
  • Zycubo (copper histidinate)
    +
    lomustine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lomustine

    monitor CBC, renal fxn, electrolytes: combo may incr. lomustine levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • lonafarnib
  • Zycubo (copper histidinate)
    +
    lonafarnib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lonafarnib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • loncastuximab tesirine
  • Zycubo (copper histidinate)
    +
    loncastuximab tesirine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + loncastuximab tesirine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • losartan
  • Zycubo (copper histidinate)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + losartan

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • lovotibeglogene autotemcel
  • Zycubo (copper histidinate)
    +
    lovotibeglogene autotemcel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lovotibeglogene autotemcel

    monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression, bleeding (additive effects)

  • lurbinectedin
  • Zycubo (copper histidinate)
    +
    lurbinectedin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lurbinectedin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • lutetium Lu 177 dotatate
  • Zycubo (copper histidinate)
    +
    lutetium Lu 177 dotatate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lutetium Lu 177 dotatate

    monitor CBC, renal function, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • lutetium Lu 177 vipivotide tetraxetan
  • Zycubo (copper histidinate)
    +
    lutetium Lu 177 vipivotide tetraxetan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lutetium Lu 177 vipivotide tetraxetan

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • lymphocyte immune globulin, anti-thymocyte globulin
  • Zycubo (copper histidinate)
    +
    lymphocyte immune globulin, anti-thymocyte globulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + lymphocyte immune globulin, anti-thymocyte globulin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • magnesium citrate
  • Zycubo (copper histidinate)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + magnesium citrate

    monitor renal fxn, electrolytes, especially if magnesium citrate bowel prep use: combo may incr. risk of nephrotoxicity (additive effects)

  • magnesium salicylate
  • Zycubo (copper histidinate)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + magnesium salicylate

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • marnetegragene autotemcel
  • Zycubo (copper histidinate)
    +
    marnetegragene autotemcel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + marnetegragene autotemcel

    monitor CBC, bleeding signs/symptoms: combo may incr. risk of myelosuppression (additive effects)

  • meclofenamate
  • Zycubo (copper histidinate)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + meclofenamate

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • mefenamic acid
  • Zycubo (copper histidinate)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mefenamic acid

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • meloxicam
  • Zycubo (copper histidinate)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    copper histidinate + meloxicam

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • melphalan
  • Zycubo (copper histidinate)
    +
    melphalan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + melphalan

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • mercaptopurine
  • Zycubo (copper histidinate)
    +
    mercaptopurine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mercaptopurine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • mesalamine
  • Zycubo (copper histidinate)
    +
    mesalamine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mesalamine

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • mesalamine rectal
  • Zycubo (copper histidinate)
    +
    mesalamine rectal
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mesalamine rectal

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • metolazone
  • Zycubo (copper histidinate)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    copper histidinate + metolazone

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • midostaurin
  • Zycubo (copper histidinate)
    +
    midostaurin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + midostaurin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • mitomycin
  • Zycubo (copper histidinate)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mitomycin

    monitor CBC, renal fxn, electrolytes; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • mitotane
  • Zycubo (copper histidinate)
    +
    mitotane
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mitotane

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • mitoxantrone
  • Zycubo (copper histidinate)
    +
    mitoxantrone
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mitoxantrone

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • moexipril
  • Zycubo (copper histidinate)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + moexipril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • mogamulizumab
  • Zycubo (copper histidinate)
    +
    mogamulizumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mogamulizumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • momelotinib
  • Zycubo (copper histidinate)
    +
    momelotinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + momelotinib

    monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression (additive effects)

  • mosunetuzumab
  • Zycubo (copper histidinate)
    +
    mosunetuzumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mosunetuzumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • mycophenolate mofetil
  • Zycubo (copper histidinate)
    +
    mycophenolate mofetil
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mycophenolate mofetil

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • mycophenolic acid
  • Zycubo (copper histidinate)
    +
    mycophenolic acid
    1 interaction

    Monitor/Modify Tx

    copper histidinate + mycophenolic acid

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • nabumetone
  • Zycubo (copper histidinate)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    copper histidinate + nabumetone

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • naproxen
  • Zycubo (copper histidinate)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    copper histidinate + naproxen

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • nelarabine
  • Zycubo (copper histidinate)
    +
    nelarabine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + nelarabine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • neomycin
  • Zycubo (copper histidinate)
    +
    neomycin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + neomycin

    if compromised gut wall allows for neomycin absorption, monitor renal fxn, electrolytes, ototoxicity: combo may incr. neomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • nilotinib
  • Zycubo (copper histidinate)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + nilotinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • niraparib
  • Zycubo (copper histidinate)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + niraparib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • nusinersen
  • Zycubo (copper histidinate)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    copper histidinate + nusinersen

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • obecabtagene autoleucel
  • Zycubo (copper histidinate)
    +
    obecabtagene autoleucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + obecabtagene autoleucel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • obinutuzumab
  • Zycubo (copper histidinate)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + obinutuzumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ofatumumab
  • Zycubo (copper histidinate)
    +
    ofatumumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ofatumumab

    monitor CBC; myelosuppression risk may be lower w/ ofatumumab doses used for MS: combo may incr. risk of myelosuppression (additive effects)

  • olaparib
  • Zycubo (copper histidinate)
    +
    olaparib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + olaparib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • olmesartan medoxomil
  • Zycubo (copper histidinate)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    copper histidinate + olmesartan medoxomil

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • olsalazine
  • Zycubo (copper histidinate)
    +
    olsalazine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + olsalazine

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • oxaprozin
  • Zycubo (copper histidinate)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + oxaprozin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • paclitaxel
  • Zycubo (copper histidinate)
    +
    paclitaxel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + paclitaxel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • pacritinib
  • Zycubo (copper histidinate)
    +
    pacritinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pacritinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • palbociclib
  • Zycubo (copper histidinate)
    +
    palbociclib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + palbociclib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • pamidronate
  • Zycubo (copper histidinate)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pamidronate

    monitor renal fxn, electrolytes: combo may incr. pamidronate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • paromomycin
  • Zycubo (copper histidinate)
    +
    paromomycin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + paromomycin

    if compromised gut wall allows for paromomycin absorption, monitor renal fxn, electrolytes, ototoxicity: combo may incr. paromomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • pazopanib
  • Zycubo (copper histidinate)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pazopanib

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • peginterferon alfa 2a
  • Zycubo (copper histidinate)
    +
    peginterferon alfa 2a
    1 interaction

    Monitor/Modify Tx

    copper histidinate + peginterferon alfa 2a

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • peginterferon beta 1a
  • Zycubo (copper histidinate)
    +
    peginterferon beta 1a
    1 interaction

    Monitor/Modify Tx

    copper histidinate + peginterferon beta 1a

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • pemetrexed
  • Zycubo (copper histidinate)
    +
    pemetrexed
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pemetrexed

    monitor CBC, renal fxn, electrolytes: combo may incr. pemetrexed levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • pentostatin
  • Zycubo (copper histidinate)
    +
    pentostatin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pentostatin

    monitor CBC, renal fxn, electrolytes: combo may incr. pentostatin levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • perindopril
  • Zycubo (copper histidinate)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + perindopril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • piroxicam
  • Zycubo (copper histidinate)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    copper histidinate + piroxicam

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • pirtobrutinib
  • Zycubo (copper histidinate)
    +
    pirtobrutinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pirtobrutinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • plazomicin
  • Zycubo (copper histidinate)
    +
    plazomicin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + plazomicin

    monitor plazomicin levels, renal fxn, electrolytes, ototoxicity: combo may incr. plazomicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • polatuzumab vedotin
  • Zycubo (copper histidinate)
    +
    polatuzumab vedotin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + polatuzumab vedotin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • polyethylene glycol
  • Zycubo (copper histidinate)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    copper histidinate + polyethylene glycol

    monitor renal fxn, electrolytes, especially if polyethylene glycol bowel prep use: combo may incr. risk of nephrotoxicity (additive effects)

  • polyethylene glycol/electrolytes
  • Zycubo (copper histidinate)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    copper histidinate + polyethylene glycol/ electrolytes

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • pomalidomide
  • Zycubo (copper histidinate)
    +
    pomalidomide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pomalidomide

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ponatinib
  • Zycubo (copper histidinate)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ponatinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • pralatrexate
  • Zycubo (copper histidinate)
    +
    pralatrexate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pralatrexate

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • procarbazine
  • Zycubo (copper histidinate)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + procarbazine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • proguanil
  • Zycubo (copper histidinate)
    +
    proguanil
    1 interaction

    Monitor/Modify Tx

    copper histidinate + proguanil

    monitor CBC, especially if concomitant renal impairment: combo may incr. risk of myelosuppression (additive effects)

  • pyrimethamine
  • Zycubo (copper histidinate)
    +
    pyrimethamine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + pyrimethamine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • quinapril
  • Zycubo (copper histidinate)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + quinapril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • quizartinib
  • Zycubo (copper histidinate)
    +
    quizartinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + quizartinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ramipril
  • Zycubo (copper histidinate)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ramipril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • ramucirumab
  • Zycubo (copper histidinate)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ramucirumab

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • relacorilant
  • Zycubo (copper histidinate)
    +
    relacorilant
    1 interaction

    Monitor/Modify Tx

    copper histidinate + relacorilant

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • Rho(D) immune globulin
  • Zycubo (copper histidinate)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + Rho(D) immune globulin

    monitor renal fxn, electrolytes; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • ribavirin
  • Zycubo (copper histidinate)
    +
    ribavirin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ribavirin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ribociclib
  • Zycubo (copper histidinate)
    +
    ribociclib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ribociclib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • rifabutin
  • Zycubo (copper histidinate)
    +
    rifabutin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + rifabutin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • rituximab
  • Zycubo (copper histidinate)
    +
    rituximab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + rituximab

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • romidepsin
  • Zycubo (copper histidinate)
    +
    romidepsin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + romidepsin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • rucaparib
  • Zycubo (copper histidinate)
    +
    rucaparib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + rucaparib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ruxolitinib
  • Zycubo (copper histidinate)
    +
    ruxolitinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ruxolitinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ruxolitinib topical
  • Zycubo (copper histidinate)
    +
    ruxolitinib topical
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ruxolitinib topical

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • sacituzumab govitecan
  • Zycubo (copper histidinate)
    +
    sacituzumab govitecan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sacituzumab govitecan

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • salsalate
  • Zycubo (copper histidinate)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + salsalate

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • sarilumab
  • Zycubo (copper histidinate)
    +
    sarilumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sarilumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • satralizumab
  • Zycubo (copper histidinate)
    +
    satralizumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + satralizumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • selinexor
  • Zycubo (copper histidinate)
    +
    selinexor
    1 interaction

    Monitor/Modify Tx

    copper histidinate + selinexor

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • sirolimus
  • Zycubo (copper histidinate)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sirolimus

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • sirolimus albumin-bound
  • Zycubo (copper histidinate)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sirolimus albumin-bound

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • sitagliptin
  • Zycubo (copper histidinate)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sitagliptin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • sodium picosulfate
  • Zycubo (copper histidinate)
    +
    sodium picosulfate
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sodium picosulfate

    monitor renal function, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • sparsentan
  • Zycubo (copper histidinate)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sparsentan

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • spironolactone
  • Zycubo (copper histidinate)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    copper histidinate + spironolactone

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • stiripentol
  • Zycubo (copper histidinate)
    +
    stiripentol
    1 interaction

    Monitor/Modify Tx

    copper histidinate + stiripentol

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • succimer
  • Zycubo (copper histidinate)
    +
    succimer
    1 interaction

    Monitor/Modify Tx

    copper histidinate + succimer

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • sulfasalazine
  • Zycubo (copper histidinate)
    +
    sulfasalazine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sulfasalazine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • sulfate bowel prep
  • Zycubo (copper histidinate)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sulfate bowel prep

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • sulindac
  • Zycubo (copper histidinate)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sulindac

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • sunitinib
  • Zycubo (copper histidinate)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + sunitinib

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • tacrolimus
  • Zycubo (copper histidinate)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tacrolimus

    monitor tacrolimus levels, renal fxn, electrolytes: combo may incr. tacrolimus levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tafasitamab
  • Zycubo (copper histidinate)
    +
    tafasitamab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tafasitamab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • tagraxofusp
  • Zycubo (copper histidinate)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tagraxofusp

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • talazoparib
  • Zycubo (copper histidinate)
    +
    talazoparib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + talazoparib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • talquetamab
  • Zycubo (copper histidinate)
    +
    talquetamab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + talquetamab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • tarlatamab
  • Zycubo (copper histidinate)
    +
    tarlatamab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tarlatamab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • tazemetostat
  • Zycubo (copper histidinate)
    +
    tazemetostat
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tazemetostat

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • teclistamab
  • Zycubo (copper histidinate)
    +
    teclistamab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + teclistamab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • telavancin
  • Zycubo (copper histidinate)
    +
    telavancin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + telavancin

    monitor ECG, renal fxn, electrolytes: combo may incr. telavancin levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (additive effects)

  • telmisartan
  • Zycubo (copper histidinate)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + telmisartan

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • temozolomide
  • Zycubo (copper histidinate)
    +
    temozolomide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + temozolomide

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • temsirolimus
  • Zycubo (copper histidinate)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    copper histidinate + temsirolimus

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • tenofovir alafenamide
  • Zycubo (copper histidinate)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tenofovir alafenamide

    monitor renal fxn, electrolytes: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • teplizumab
  • Zycubo (copper histidinate)
    +
    teplizumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + teplizumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • teriflunomide
  • Zycubo (copper histidinate)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + teriflunomide

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • thalidomide
  • Zycubo (copper histidinate)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + thalidomide

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • thioguanine
  • Zycubo (copper histidinate)
    +
    thioguanine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + thioguanine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • thiotepa
  • Zycubo (copper histidinate)
    +
    thiotepa
    1 interaction

    Monitor/Modify Tx

    copper histidinate + thiotepa

    monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression (additive effects)

  • tiopronin
  • Zycubo (copper histidinate)
    +
    tiopronin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tiopronin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • tisagenlecleucel
  • Zycubo (copper histidinate)
    +
    tisagenlecleucel
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tisagenlecleucel

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • tivozanib
  • Zycubo (copper histidinate)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tivozanib

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • tobramycin
  • Zycubo (copper histidinate)
    +
    tobramycin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tobramycin

    use alternative or monitor tobramycin levels, renal fxn, electrolytes, ototoxicity: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tocilizumab
  • Zycubo (copper histidinate)
    +
    tocilizumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tocilizumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • tofacitinib
  • Zycubo (copper histidinate)
    +
    tofacitinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tofacitinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • tolmetin
  • Zycubo (copper histidinate)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + tolmetin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • topotecan
  • Zycubo (copper histidinate)
    +
    topotecan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + topotecan

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • torsemide
  • Zycubo (copper histidinate)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + torsemide

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • trabectedin
  • Zycubo (copper histidinate)
    +
    trabectedin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + trabectedin

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • trandolapril
  • Zycubo (copper histidinate)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    copper histidinate + trandolapril

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • trastuzumab
  • Zycubo (copper histidinate)
    +
    trastuzumab
    1 interaction

    Monitor/Modify Tx

    copper histidinate + trastuzumab

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • treosulfan
  • Zycubo (copper histidinate)
    +
    treosulfan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + treosulfan

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • triamterene
  • Zycubo (copper histidinate)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    copper histidinate + triamterene

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • trifluridine
  • Zycubo (copper histidinate)
    +
    trifluridine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + trifluridine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • trimethoprim
  • Zycubo (copper histidinate)
    +
    trimethoprim
    1 interaction

    Monitor/Modify Tx

    copper histidinate + trimethoprim

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • upadacitinib
  • Zycubo (copper histidinate)
    +
    upadacitinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + upadacitinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • vaccinia immune globulin
  • Zycubo (copper histidinate)
    +
    vaccinia immune globulin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + vaccinia immune globulin

    monitor renal fxn, electrolytes; use lowest vaccinia immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

  • valacyclovir
  • Zycubo (copper histidinate)
    +
    valacyclovir
    1 interaction

    Monitor/Modify Tx

    copper histidinate + valacyclovir

    monitor renal fxn, electrolytes: combo may incr. acyclovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • valproic acid
  • Zycubo (copper histidinate)
    +
    valproic acid
    1 interaction

    Monitor/Modify Tx

    copper histidinate + valproic acid

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • valsartan
  • Zycubo (copper histidinate)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    copper histidinate + valsartan

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • vancomycin
  • Zycubo (copper histidinate)
    +
    vancomycin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + vancomycin

    VANCOMYCIN IV: monitor CBC, renal fxn, electrolytes, vancomycin levels, ototoxicity; VANCOMYCIN PO: monitor CBC, renal fxn, electrolytes; consider monitoring vancomycin levels, ototoxicity in pts w/ severe renal impairment, severe intestinal inflammation, or prolonged course >2 g/day: combo may incr. vancomycin levels, risk of nephrotoxicity, myelosuppression, auditory, vestibular, other adverse effects (additive effects; incr. oral vancomycin absorption if inflamed or compromised gut mucosa)

  • venetoclax
  • Zycubo (copper histidinate)
    +
    venetoclax
    1 interaction

    Monitor/Modify Tx

    copper histidinate + venetoclax

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • vinblastine
  • Zycubo (copper histidinate)
    +
    vinblastine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + vinblastine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • vincristine
  • Zycubo (copper histidinate)
    +
    vincristine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + vincristine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • vinorelbine
  • Zycubo (copper histidinate)
    +
    vinorelbine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + vinorelbine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • voclosporin
  • Zycubo (copper histidinate)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    copper histidinate + voclosporin

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • willow bark
  • Zycubo (copper histidinate)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    copper histidinate + willow bark

    monitor renal fxn, electrolytes, especially w/ high-dose willow bark: combo may incr. risk of nephrotoxicity (additive effects, willow bark may contain salicylates)

  • zanubrutinib
  • Zycubo (copper histidinate)
    +
    zanubrutinib
    1 interaction

    Monitor/Modify Tx

    copper histidinate + zanubrutinib

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • zidovudine
  • Zycubo (copper histidinate)
    +
    zidovudine
    1 interaction

    Monitor/Modify Tx

    copper histidinate + zidovudine

    monitor CBC: combo may incr. risk of myelosuppression (additive effects)

  • ziv-aflibercept
  • Zycubo (copper histidinate)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    copper histidinate + ziv-aflibercept

    monitor CBC, renal fxn, electrolytes: combo may incr. risk of myelosuppression, nephrotoxicity (additive effects)

  • zoledronic acid
  • Zycubo (copper histidinate)
    +
    zoledronic acid
    1 interaction

    Monitor/Modify Tx

    copper histidinate + zoledronic acid

    monitor renal fxn, electrolytes: combo may incr. zoledronic acid levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • zonisamide
  • Zycubo (copper histidinate)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    copper histidinate + zonisamide

    monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@1f2707d5
  • renal tubular toxicity
  • hepatotoxicity
  • bone marrow dysfunction
  • spleen dysfunction
  • seizures
  • respiratory infection
  • respiratory failure
  • cardiopulmonary failure
  • hypovolemia

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@1cb5f8a6
  • pneumonia
  • infection
  • respiratory failure
  • seizures
  • hemorrhage
  • hypotension
  • vomiting
  • tachycardia
  • fever
  • volume depletion
  • fracture
  • dyspnea
  • transaminase elevation
  • diarrhea
  • anemia
  • injection site reaction

Safety/Monitoring .

Monitoring Parameters
BUN/Cr, electrolytes, CBC, LFTs, serum copper and ceruloplasmin levels at baseline, then q6wk x6mo, then q3mo x18mo, then q6mo

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; no human or animal data available

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@398b6659

Metabolism: for copper histidinate: unknown; CYP450: unknown

Excretion: for copper histidinate: bile; Half-life: 75h

Subclass: Inherited Metabolic Disorders

Mechanism of Action
for copper histidinate: directly supplies bioavailable copper ions, increasing serum copper and ceruloplasmin concentrations

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Sentynl Therapeutics, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@578c8e85

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information